FDA Committee Says Vascepa Can Be Given To Larger Population Of Patients
1:04
An Update on Vascepa® and Heart Health | Leonard Pianko MD
6:16
Vascepa (Icosapent Ethyl): The Omega-3 That Lowers Heart Risk | High Triglycerides Explained
8:18
#4 THE TRUTH ABOUT VASCEPA/VAZKEPA (ICOSAPENT ETHYL)
7:47
What is VASCEPA? THE FISH OIL THAT WORKS!! | Dr. Curnew MD
4:21
Vascepa: Current Uses and Emerging Results from REDUCE-IT
3:20
What you need to know about Lovaza and Vascepa?
4:28
Amarin CEO on Vascepa heart drug trial
5:30
Vascepa Is Safe and Should Be Approved by End of Year, Amarin CEO Says
5:22
Robert Busch, MD: REDUCE-IT Trial Implications, Icosapent Ethyl for Diabetes Patients
1:46
Reducing Risk in Hypertriglyceridemia (REDUCE-IT Trial)
7:14
New trick for old drug; Vascepa cost effective for CV reduction
1:58
Prescription Drug With Fish Oil Reduces Risk Of Heart Attack, Study Finds | NBC Nightly News
2:09
New Super Fish Oil Drug May Cut Heart Disease Risk
3:03
Considerations for Treating With Icosapent Ethyl
3:38
Five commonly asked questions about Icosapent Ethyl?
3:16
Side Effects of Purified Bile Salts – Dr. Berg
6:26
Amarin CEO on Future of Heart Drug Vascepa